Relevant bibliographies by topics / Uterine fibroids

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Uterine fibroids'

Author: Grafiati
Published: 4 June 2021
Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Uterine fibroids.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Uterine fibroids"

1

Nadir qızı Kərimova, Sevinc. "Uterine fibroids." NATURE AND SCIENCE 07, no. 02 (April 23, 2021): 22–24. http://dx.doi.org/10.36719/2707-1146/07/22-24.

Full text
Abstract:
Fibroids (especially large ones) deform the uterine cavity, compressing the fallopian tubes, making it difficult for sperm to move. In addition, in women with fibroids, in many cases, the hormonal background is disturbed, as a result of which a woman may not ovulate. The factors we have listed can lead to infertility in women. Doctors recommend women with fibroids to treat fibroids during the planning stage of pregnancy or, in some cases, to remove fibroids before pregnancy. A woman can plan a pregnancy 6 months after the fibroid is removed. Key words: fibroma, uterus, pregnancy
APA, Harvard, Vancouver, ISO, and other styles
2

Golubka, Paweł, Agnieszka Wańkowicz, Marian Przylepa, Marek Gogacz, Ivan Golubka, Kristiana Golubka, Dominik Dłuski, Wiktoria Golubka, and Dorota Darmochwał-Kolarz. "Pregnant women suffering from uterine fibroids." Polish Journal of Public Health 125, no. 3 (September 1, 2015): 166–68. http://dx.doi.org/10.1515/pjph-2015-0047.

Full text
Abstract:
Abstract Introduction. Uterine fibroids are the most frequent benign tumors affecting sexual organs in women. It is estimated that they affect 20% of the female population, with the frequency in pregnant women ranging between 0.1-5%. In spite of the progress in the field of medicine, the actual cause of uterine fibroids has yet to be discovered. Aim. Analysis of the recent methods of dealing with uterine fibroids during pregnancy. Material and methods. A review of literature about dealing with pregnant, lying-in and parturient women suffering from uterine fibroids. Results. The research studies by Aydeniz, Vergani, Rice showed that cesarean sections are much more frequent in pregnant women with uterine fibroids than in control group (52.9% vs 27.9%; 23% vs 12%; 35.1% vs 21.5%). However, it was shown that the rate of cesarean sections was much higher in women with uterine fibroids located in the lower part of the uterus than in the fundus uteri (respectively 39% and 18%). Also, the rate increased when the diameter of the fibroid exceeded 5 cm, unlike in case of those smaller than 5 cm (respectively 35% and 17%). Conclusions. 1. The number of cesarean sections in women with uterine fibroids is higher than in control group. 2. The frequency of cesarean sections in pregnancies with uterine fibroids depends on their position and size. 3. There is no relationship between the number of complications and the amount of fibroids in pregnant women. 4. There is no agreement concerning the recommendations for removing the fibroid during cesarean section.
APA, Harvard, Vancouver, ISO, and other styles
3

Carrino, David A., Sam Mesiano, Nichole M. Barker, William W. Hurd, and Arnold I. Caplan. "Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition." Biochemical Journal 443, no. 2 (March 27, 2012): 361–68. http://dx.doi.org/10.1042/bj20111996.

Full text
Abstract:
Fibrosis is the formation of excess and abnormal fibrous connective tissue as a result of either a reparative or reactive process. A defining feature of connective tissue is its extracellular matrix, which provides structural support and also influences cellular activity. Two common human conditions that result from fibrosis are uterine fibroids (leiomyomas) and keloid scars. Because these conditions share a number of similarities and because their growth is due primarily to excessive extracellular matrix deposition, we compared the proteoglycans of uterine fibroids and keloid scars with corresponding normal tissues. Our analysis indicates that uterine fibroids and keloid scars contain higher amounts of glycosaminoglycans relative to normal myometrium and normal adult skin respectively. Proteoglycan composition is also different in the fibrotic tissues. Compared with unaffected tissues, uterine fibroids and keloid scars contain higher relative amounts of versican and lower relative amounts of decorin. There is also evidence for a higher level of versican catabolism in the fibrotic tissues compared with unaffected tissues. These qualitative and quantitative proteoglycan differences may play a role in the expansion of these fibroses and in their excessive matrix deposition and matrix disorganization, due to effects on cell proliferation, TGF (transforming growth factor)-β signalling and/or collagen fibril formation.
APA, Harvard, Vancouver, ISO, and other styles
4

Khan, Maimoona Qadir, Zubeida Akhtar, and Jamila M. Naib. "Uterine Fibroids in Pregnancy." Journal of Gandhara Medical and Dental Science 9, no. 3 (July 1, 2022): 30–33. http://dx.doi.org/10.37762/jgmds.9-3.314.

Full text
Abstract:
OBJECTIVES: To determine the maternal and fetal outcomes associated with uterine fibroids in pregnancy. METHODOLOGY: This study was conducted in the Gynaecology Department of Mardan Medical Complex from January 2018 to December 2019. All pregnant women of any age or parity or gestational age with sonographic evidence of uterine fibroids were included. Demographic details, gestational age, symptoms related to fibrosis, size, number and location of the fibroid, mode of delivery, antenatal, intrapartum and postnatal complication, and neonatal outcome were entered in a predesigned proforma. RESULTS: The incidence of uterine fibroids in pregnancy was 0.8%.77 patients were enrolled. The mean age was 26.5 + 3.22 years. The mode of delivery was a caesarean section in 32.4%, and vaginal delivery in 53% of patients.14% of patients miscarried. Fibroids were multiple in 58.4% and single in 41.5% of patients. Submucosal fibroids were seen in 23%, intramural in 18% and subserosal in 58% of cases. The most common maternal complication was abdominal pain (25%), followed by postpartum haemorrhage(23%) and antepartum haemorrhage(19%). Neonatal outcome was good, with 57% of babies being healthy and 9% being admitted to the Neonatal Intensive Care Unit (NICU) and discharged later. CONCLUSION: Pregnant women with fibroids should be cautiously screened during antenatal to avoid obstetric complications.
APA, Harvard, Vancouver, ISO, and other styles
5

Abdelmtalab, Mohammed A. A., O. Tahir, K. Hussein, and Kamal Badawi. "Anatomical locations of uterine fibroids in Sudanese women." Anatomy Journal of Africa 9, no. 1 (April 5, 2020): 1701–6. http://dx.doi.org/10.4314/aja.v9i1.6.

Full text
Abstract:
Uterine fibroids are the commonest uterine neoplasms, they are benign tumors of smooth muscle origin. The study was done to look for the anatomical locations of uterine fibroids and their incidence in Sudanese women at Omdurman Maternity Hospital between 1st July 2014 to 5th October 2015. Their sociodemographic and ultrasound data were collected using a prepared questionnaire. The study included 138 confirmed cases of uterine fibroids out of 2968 investigated cases representing incidence rate of 4.6%. The highest incidence was found in the age group 36-40 years. Most dominant anatomical locations of uterine fibroids were intramural as a single mass (34.78%), followed by the intramural-subserosal in multiple masses (20.29%). The anatomical positions of uterine fibroids, posterior position was seen in (27.5%) which was the most dominant in single uterine fibroid mass, followed by the anterior-posterior position in multiple uterine one (18.1%). Intramural anatomical locations in single mass are the commonest uterine fibroids types which affect the Sudanese women. Key words: Anatomical locations; Uterine fibroid and leiomyomas
APA, Harvard, Vancouver, ISO, and other styles
6

Alhainiah, Maha, Elaf Aljifry, Ayman Alghamdi, Lujain Alrabghi, Abdullah Alharbi, Ezdehar Alrowaithi, Fatimah Almuallem, Elaf Fakeih, Bassmah Alrowaithi, and Hassan Allam. "Safety of pregnancy in uterine fibroids." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 7, no. 8 (July 26, 2018): 2985. http://dx.doi.org/10.18203/2320-1770.ijrcog20182924.

Full text
Abstract:
Uterine fibroid is one of the most common intrauterine masses among females at the reproductive age. Pregnancy and uterine fibroids are highly correlated. Pregnancy-related hormones influence the size of uterine fibroids, and fibroids have many impacts on pregnancy. Although most if the uterine fibroids are asymptomatic during pregnancy, serious complications may occur. The main complications include abortion, premature rupture of membranes, premature labor, abruptio placentae, peripartum hemorrhage, fetal malpresentation, fetal intrauterine growth retardation, small for gestational age infants, and fetal anomalies. The main risk factors for complications are related to the fibroid number, size, volume, location, and type. Large, multiple, retroplacental, submucosal, subserosal, pedunculated, or low-lying fibroids carries the highest risk for complications during pregnancy. This review will address the prevalence of uterine fibroids during pregnancy, its effects, and complications.
APA, Harvard, Vancouver, ISO, and other styles
7

Islam, Dr Md Menhazul, Dr Farzana Alam, Dr Syeeda Showkat, Dr Muhammad Mahbubur Rahman, Dr Mahbuba Shirin, Dr Hafiza Lona, Dr Md Mahbubur Rahman, and Dr Shahjada Selim. "Impact of Vitamin D Supplementation among the Women with Uterine Fibroid in Different Age Groups." Scholars Journal of Applied Medical Sciences 10, no. 11 (November 30, 2022): 2052–56. http://dx.doi.org/10.36347/sjams.2022.v10i11.042.

Full text
Abstract:
Background: Uterine fibroid (UF) is a common tumor of the female reproductive system. Though most of the women with fibroids are asymptomatic, approximately 30% of them can mention about some severe symptoms like abnormal uterine bleeding, pelvic pain, anemia, back pain, urinary frequency and even infertility etc. Generally, among the patients with uterine fibroids, prevalence of vitamin D deficiency is found. But, the impact of vitamin D on reduction of the sizes the uterine fibroids are still unknown. Aim of the study: The aim of this study was to assess the impact of vitamin D supplementation among the women with uterine fibroid in different age groups. Methods: This prospective observational study was conducted in the department of Radiology & Imaging, BSMMU, Dhaka, Bangladesh during the period from January 2020 to December 2020. In total 75 women with uterine fibroid were enrolled in this study as study population. Before data collection proper written consents were taken from all the participants. Along with the data regarding fibroids and vitamin D status, all the demographic and clinical data were collected and analyzed. In data collection, a predesigned questioner was used. All data were processed, analyzed and disseminated by using MS Excel and SPSS version 23.0 program as per necessity. Results: In this study, in assessing the fibroid’s sizes of several age group patients, between baseline and follow-up we found that, at baseline, in 20-30, 31-45 and >45 year’s age groups, the mean ±SD sizes of fibroids were 3.32±0.46, 3.91±0.50 and 4.05±0.51 cm respectively. On the other hand, at follow-up stage in those groups the mean ±SD sizes of fibroids were found as 2.64 ±0.40, 3.66±0.48 and 3.5±0.47 cm respectively. Finally, in evaluating the impact of vitamin D supplementation among our participants, comparing the fibroid sizes between baseline and follow-up stages, we observed that, in >45 years’ age group the fibroid size change was non-significant (P<0.05). ..
APA, Harvard, Vancouver, ISO, and other styles
8

Made Indira Dianti Sanjiwani and I Made Widianantara. "Peranan Resveratrol terhadap Progresivitas Uterine Fibroid." KELUWIH: Jurnal Kesehatan dan Kedokteran 2, no. 2 (June 30, 2021): 102–9. http://dx.doi.org/10.24123/kesdok.v2i2.4189.

Full text
Abstract:
Uterine fibroids or leiomyomas are benign neoplasms that occur in the uterus and still become a health problem among women of reproductive age. Predominantly, uterine fibroids are found at productive age but some cases are found after menopause. Based on previous studies, there were 145 cases of uterine fibroids in 2014 and 69.7% were found in women over 40 years. Patients with uterine fibroids show a decreased quality of life with symptoms such as heavy uterine bleeding, pelvic pain, and loss of pregnancy. The pathogenesis of uterine fibroids is still unknown, but genetic factors, cytokines, growth factors, and steroid hormones are weak and play an important role in the development of uterine fibroids. Several studies have shown the effect of resveratrol that can be obtained from grape skins. Resveratrol can reduce extracellular matrix deposition and uterine fibroid cell proliferation. Looking at the induced events then resveratrol is effective in preventing the progression of uterine fibroids.
APA, Harvard, Vancouver, ISO, and other styles
9

Yadav, Rajni, Isotou Drammeh, and Mahendra Kumar Sahu. "Exploring uterine fibroids and its treatment in current scenario." IP International Journal of Comprehensive and Advanced Pharmacology 8, no. 3 (November 15, 2023): 143–48. http://dx.doi.org/10.18231/j.ijcaap.2023.025.

Full text
Abstract:
Uterine Fibroids (leiomyoma) are made of muscle cells and other grow tissues grow in and around of the wall of the uterus. Uterine fibroids benign tumors in women reproduction age worldwide. Many are discovered incidentally on clinically examination. Approximately 30% of women with uterine fibroids will present with severe symptoms, which can include abdominal uterine bleeding, anemia, pelvic pain and constipation. Infertility and recurrent miscarriage may also be symptoms of fibroids, depending on their location and size, especially for sub mucous and intramural myelomas distorting the uterine cavity. Current option for symptomatic fibroid treatment includes expectant medical and surgical management radiology procedures. Ultrasound can be done, when a patient is symptomatic of uterine fibroids. Fibroids are generally classified by their location; intramural fibroids, subserosal fibroids, submucosal fibroids. The cause of uterine fibroids is unknown, But research and clinical experience proposes that genetics, hormonal imbalance, other growth factor and extracellular matrix accumulation could be the contributing factors .Although uterine fibroids are usually not dangerous, they can cause discomfort and lead to complication such as, drop in red blood cell (anemia) which causes fatigue from heavy bleeding. Our aim is to highlight the new treatments and advancements in treating uterine fibroids. Later we have also highlighted the future advancements and innovations that are used in developed countries for same.
APA, Harvard, Vancouver, ISO, and other styles
10

Poly, Rosemol, Anju Alex, and Usha Christopher. "Wandering Uterine Leiomyoma: A Case Report." International Journal of Research and Review 10, no. 3 (March 10, 2023): 10–12. http://dx.doi.org/10.52403/ijrr.20230303.

Full text
Abstract:
Wandering fibroids, commonly referred to as parasitic fibroids, are a relatively uncommon kind of extrauterine benign tumour in women of reproductive age. It has no myometrial connections and frequently develops in conjunction with other abdominopelvic structures' blood supply. Due to their odd placements and symptoms, these fibroids are challenging to diagnose by imaging. There are several hypotheses on the origin of parasitic fibroids, including the iatrogenic seeding of fibroid pieces after morcellation in laparoscopic myomectomy, and pedunculated subserosal fibroid separating from its stalk and joining other abdominopelvic structures. We discuss a case of parasitic fibroid in a 41-year-old nulliparous woman who suffered from abdominal pain and whose usg findings were indicative of an atypical fibroid in this report (broad ligament fibroid).
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Uterine fibroids"

1

Barbosa, Lígia Flávia da Silva. "Epidemiological factors associated with uterine fibroids." Master's thesis, Universidade da Beira Interior, 2012. http://hdl.handle.net/10400.6/1066.

Full text
Abstract:
Introduction: The uterine fibroids are the most common benign neoplasm in the female genital tract. However, the prevalence of this disease in the general population is unknown, which justifies this investigation. Objective: To evaluate epidemiological factors associated with uterine myomas, in a setting of a private medical clinic. Methodology: It is presented as a cross-sectional research, drafted with a descriptive and an analytical component. To collect data a routine demographic computerized file was kept for every patient and a pelvic transvaginal or transrectal ultrasonography was performed. We retrieved from each patient their age at the time of consultation, weight, height, age of menarche, number of pregnancies, pregnancy outcome, marital status, level of education, menstrual cycle and contraceptive method used. Through the ultrasound examination, we recorded the presence of uterine myomas, their number and the largest dimension of the biggest myoma. Results: From the total women studied by ultrasonography (n = 624), uterine myomas were documented in 161 (25,8%) cases. Single myomas were presented in 49,7% (n = 80) and the majority of women had small fibroids, between 10 mm to 19 mm (41,6%, n = 67). Ages between 40 and 59 years, married marital status, overweight, menopause, previous pregnancy and delivery and complaints of menorrhagia were associated with a higher risk for uterine fibroids. The use of combined hormonal contraceptives was found to be a protective factor. Since these variables, after conducting a multivariate analysis, were all age dependent, we can suggest that aging is the only factor associated with the presence of uterine fibroids. Menorrhagia, metrorrhagia and pelvic pain were associated with a higher risk for multiple uterine fibroids. The use of combined hormonal contraceptives was associated with a higher risk for single fibroids. Ages between 40 and 59 years and a history of pregnancy and delivery were associated with a smaller dimension of the leiomyomas. Conclusion: Uterine myoma is a very common pathology among the female population. In our study, the only risk factor related with uterine fibroids was aging. Pregnacy and delivery seem to be associated with myomas of a smaller dimension. Single myoma is more common in patients using combined hormonal contraception.
APA, Harvard, Vancouver, ISO, and other styles
2

Quinn, Stephen. "Uterine fibroids : response to novel treatment modalities." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24737.

Full text
Abstract:
Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive, thermal ablation treatment for uterine fibroids. There is currently limited data regarding the long-term efficacy of this method and the effect of this treatment on circulating cytokine and growth factors. In this thesis I have: 1. Presented the most accurate method of measuring fibroid volumes, and propose a new classification system for describing fibroid uteri. 2. Reviewed the characteristics of a cohort of uterine fibroid subjects and perform a longitudinal analysis of MRgFUS results. 3. Assessed the fibroid volume treated, pain scores and cytokine levels and growth factor levels following MRgFUS and UAE. Results The Parallel Plannimetric method is an accurate and reliable method of measuring uterine, fibroid and non-perfused volumes. Classifying fibroid uteri by numbers of fibroids and the presence of dominant fibroids is useful for distinguishing between those cases to be treated by MRgFUS or UAE. Since the introduction of MRgFUS to our unit the percentage non-perfused volumes (NPV) achieved have increased from 41.22 to 50.49 (p=0.038), however the re-intervention rate at 5 years remains high at 50%. MRgFUS has an excellent safety record, and the introduction of the new ExAblate 2100 system also appears to be safe and well tolerated, with encouraging initial NPVs achieved. Following both MRgFUS and UAE circulating interleukin-6 (IL-6) is significantly raised, although this is not affected by the degree of pain experienced or the volume of fibroid treated. Following UAE there is rise in circulating vascular endothelial growth factor (VEGF) seen at one week, however no significant change in VEGF levels is seen following MRgFUS. These changes in VEGF are not related to fibroid volume. Discussion MRgFUS is a safe, well tolerated treatment for uterine fibroids, although re-intervention rate is high. Further developments in this treatment modality may continue to improve outcomes, however at present its routine use cannot be recommended.
APA, Harvard, Vancouver, ISO, and other styles
3

Harrison-Woolrych, Mira. "Studies of peptide growth factors in uterine fibroids." Thesis, University of Southampton, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.295533.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tosti, Claudia. "NEUROGENESIS IN UTERINE DISORDERS." Doctoral thesis, Università di Siena, 2019. http://hdl.handle.net/11365/1095599.

Full text
Abstract:
Endometriosis, adenomyosis and uterine fibroids represent benign gynecologic diseases, affecting women of reproductive age associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. The present knowledge indicates that hormonal function (estrogen and progesterone receptors), immunological and neuroinflammatory factors are critically altered in every of uterine disorders. The aggressive behaviour of deep infiltrating endometriosis may be explained by the highly decreased apoptosis, by the increased proliferation activity related to oxidative stress and by invasive neurogenic mechanisms and inflammatory patterns that explain its correlation with chronic pelvic pain. Adenomyotic nodules are novel site of protein expression of inflammatory and neurogenic factors, probably involved in the pathogenesis of adenomyosis: endometrial cells invade and proliferate within myometrium, and inflammatory mediators participate to the intense painful symptoms. The increased expression of neurogenic factors in uterine fibroids and endometrium may contribute to explain the painful stimuli; in addition, NGF hyperexpression, in both fibroids and endometrium, may be associated with infertility. Accordingly, in the future, these neurogenic factors may represent potential therapeutic avenues to treat the fibroid-related symptoms. 
 In conclusion, our results give new insights into the neurogenic characteristics of uterine disorders showing that endometriosis, adenomyosis and fibroids has distinct molecular patterns. With further advances in our understanding of uterine disorders, preventive strategies, novel non-surgical diagnostic modalities, and targeted therapeutics hold great promise of becoming realities and help to treat our patients. The future research may contribute to a better phenotyping of these benign gynaecological diseases in order to give a specific efficient management to each disorder. Basic science approach is necessary to increase pathogenesis knowledge of endometriosis, adenomyosis and uterine fibroids, and new medical treatment, and the clinical and diagnostic approach is necessary for planning an accurate surgical or medical treatment.
APA, Harvard, Vancouver, ISO, and other styles
5

Soucie, Jennifer Elizabeth. "Embolization therapy for uterine fibroids, a multivariate analysis of the predictive factors of fibroid response." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/MQ62934.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Doernte, Amy Lynn. "Spontaneously occurring fibroid tumors of the laying hen oviduct." Auburn, Ala., 2006. http://repo.lib.auburn.edu/2006%20Summer/Theses/DOERNTE_AMY_2.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Burroughs, Kevin Dale. "The role of ovarian hormones in the development and growth of uterine leiomyoma /." Digital version accessible at:, 1998. http://wwwlib.umi.com/cr/utexas/main.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zaher, Summia S. "Magnetic resonance guided focused ultrasound surgery : a novel treatment for uterine fibroids." Thesis, Imperial College London, 2010. http://hdl.handle.net/10044/1/5948.

Full text
Abstract:
Uterine fibroids are the most common tumour of the reproductive tract in women of reproductive age. Although they are benign tumours that are often asymptomatic, they may cause debilitating symptoms in many women, such as abnormal uterine bleeding, abdominal pain, increased abdominal girth, urinary frequency, constipation, pregnancy loss, dyspareunia, and in some cases infertility. Several approaches are available for the treatment of uterine fibroids. These include pharmacologic options, such as hormonal therapies and gonadotropinreleasing hormone agonists; surgical approaches, such as hysterectomy, myomectomy; myolysis, laparoscopic uterine artery occlusion, uterine artery embolisation and magnetic resonance imaging-guided focused ultrasound surgery. The choice of approach may be dictated by factors such as the patient’s desire to become pregnant in the future, the importance of uterine preservation, symptom severity, and tumour characteristics. There is however, no widely agreed therapeutic strategy. There is a widespread view that hysterectomy is overused in the UK; the Chief Medical Officer in his annual report ‘On the state of public health’ in 2005, highlighted that hysterectomy in younger women is associated with complications, hospital stays, procedure-related interference with normal life and is costly. In addition he outlined the need to reduce the number of hysterectomies. This, along with the change in cultural attitudes amongst patients, who are becoming increasingly reluctant to undergo these conventional invasive procedures, has increased the need for new treatment options. Ideally new treatment options for uterine fibroids would be minimally invasive, have long-term data demonstrating efficacy and safety, have minimal or no incidence of fibroid recurrence, be easy to perform, preserve fertility, and be cost effective. New treatment approaches are under investigation, with the goals of being effective, safe, and less invasive. MRgFUS is a non-invasive thermo-ablative hybrid technique which uses both MR and ultrasound to destroy tumours. It is an outpatient procedure, which avoids the need for an anaesthetic, has a short recovery period, and is uterine sparing. The main objective of this work was to set out the rationale for using Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) for the treatment of uterine fibroids. In order to achieve this aim, four main bodies of work are necessary; 1) Identifying patient selection criteria and investigating mitigating techniques to increase the pool of women for whom this treatment can be offered. 2) Investigating a method designed to overcome the problem of safely treating women with abdominal scars for whom this treatment can cause potential morbidity. 3) Investigating the potentiality of using MRgFUS to prolong the tumour shrinkage effect of GnRH analogue injections. 4) Investigating the safety of MRgFUS in treating symptomatic women who wish to preserve fertility. Results: the first aim of this project was to identify patient selection criteria and to investigate methods to widen the selection criteria. In our retrospective review it was found that 74% of women presenting were deemed technically suitable to proceed with treatment and several mitigating techniques that solved current technical difficulties were identified and allowed for less restrictive MRgFUS selection criteria for treatment of symptomatic uterine fibroids. These less restrictive criteria are expected to expand the pool of patients for whom MRgFUS is a viable treatment option for uterine fibroid symptoms. The second aim was to identify a method of overcoming the problem of treating women with previous abdominal scars safely. We identified a unique method of highlighting the scar by painting it with a paramagnetic iron oxide material which clearly outlined the scar on MR scanning allowing complete avoidance of the scar using MR guidance. In this small pilot study, all women were treated safely with no skin burns. The third aim of this project looked at the potentiality of prolonging the shrinkage effect of GnRH analogues by following a course of 3 injections with MRgFUS treatment. In this prospective study of fifty women, there was a 50% reduction in the mean symptoms severity score at 6 months which was maintained for 24 months post treatment. There was an average reduction in target fibroid volume which was maintained for 24 months. The final aim of the project was to investigate the safety of using MRgFUS as a treatment option for those women who wished to preserve their fertility. In this multicentre international study, One hundred and sixteen women were recruited from five centres. There were sixty four reported pregnancies in Sixty one women, with 30 completed deliveries. There were no reported cases of uterine rupture, premature labour, abnormal placentation or placental abruption. Conclusion: There is a growing body of data from clinical trials and more than four years of clinical experience to validate the safety and efficacy of MRgFUS for the treatment of uterine fibroids. MRgFUS is a totally non-invasive outpatient procedure that is not associated with the typical surgical risks of bleeding, infection and has minimal recovery time. Additionally, the procedure allows women to address their symptoms whilst preserving the uterus. Consequently, MRgFUS is an alternative treatment option for suitable patients who have refused other interventions due to concerns about lost productivity, risks of surgical complications or future fertility.
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Lu. "Studies of factors affecting recurrence of myoma after myomectomy." unrestricted, 2007. http://etd.gsu.edu/theses/available/etd-08052007-212426/.

Full text
Abstract:
Thesis (M.S.)--Georgia State University, 2007.
Title from title page. Yu-sheng Hsu, committee chair; Xu Zhang, Jia-wei Liu, committee members. Electronic text (44 p. : ill. (some col.)) : digital, PDF file. Description based on contents viewed Oct. 10, 2007. Includes bibliographical references (p. 35-36).
APA, Harvard, Vancouver, ISO, and other styles
10

Кузьоменська, Марина Леонідівна, Марина Леонидовна Куземенская, and Maryna Leonidivna Kuzomenska. "Оптимізація лікування хворих на міому матки." Thesis, Видавництво СумДУ, 2011. http://essuir.sumdu.edu.ua/handle/123456789/14926.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Uterine fibroids"

1

Moawad, Nash S., ed. Uterine Fibroids. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-58780-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

L, Hutchins Francis, and Greenberg Mitchell D, eds. Uterine fibroids. Philadelphia: Saunders, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Institutes of Child Health and Human Development (U.S.). Public Information and Communications Branch, ed. Uterine fibroids. [Bethesda, Md.] (31 Center Drive MSC-2425, Bethesda 10892-2425): The Institutes, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

L, Hutchins Francis, and Greenberg Mitchell D, eds. Uterine fibroids. Philadelphia: Saunders, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dubuisson, Jean-Bernard. Uterine fibroids. Paris: Arnette, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Greenberg, Mitchell D., and Francis Hutchins. Uterine fibroids. Philadelphia: W.B. Saunders, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Segars, James. Fibroids. Chichester, West Sussex: John Wiley & Sons, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sugino, Norihiro, ed. Uterine Fibroids and Adenomyosis. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-7167-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

National Institute of Child Health and Human Development (U.S.), ed. Uterine Fibroids, March 1996. [S.l: s.n., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Food and Drug Administration. Office of Women's Health. Fibroids. [Rockville, MD?]: FDA Office of Women's Health, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Uterine fibroids"

1

Leppert, Phyllis, Mazen Fouany, and James H. Segars. "Understanding Uterine Fibroids." In Fibroids, 1–10. Oxford: John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118456996.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Plewniak, Kari, and Hye-Chun Hur. "Innumerable Fibroids." In Uterine Fibroids, 347–67. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tinelli, Andrea, Leonardo Resta, Radmila Sparić, Aleksandar Stefanović, and Antonio Malvasi. "Pathogenesis, Classification, Histopathology, and Symptomatology of Fibroids." In Uterine Fibroids, 1–47. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zanotti, Kristine, and Randi Shae Connor. "The Fibroid with Red Flags!" In Uterine Fibroids, 195–215. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Song, Jonathan Y., Carlos Rotman, and Edgardo L. Yordan. "The Broad Ligament Fibroid." In Uterine Fibroids, 217–34. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rhoton-Vlasak, Alice, and Elizabeth Plasencia. "Asymptomatic Fibroids and Infertility." In Uterine Fibroids, 235–50. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Scheib, Stacey. "Solitary Myoma: Laparo-Endoscopic Single Site (LESS) Surgery." In Uterine Fibroids, 251–58. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Robinson, James. "Massive Uterine Fibroids in an Anemic Patient." In Uterine Fibroids, 259–73. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Omar, Mona, Paul C. Browne, Michael Diamond, and Ayman Al-Hendy. "Multiple Symptomatic Intramural Fibroids in a Patient Who Desires Fertility." In Uterine Fibroids, 275–94. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Liu, Grace. "The Cervical Fibroid." In Uterine Fibroids, 295–310. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-58780-6_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Uterine fibroids"

1

Vieira, Bruno Vasconcelos Borges. "Case report: calcified uterine myoma." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-085.

Full text
Abstract:
Abstract Uterine fibroids are abnormal masses of smooth muscle tissue that are usually found in the uterine body, although they can sometimes appear in the cervix. They are generally divided into three categories: subserosal (55% of cases), intramural (40%), and submucosal (5%). The exact cause of fibroids is not well established, but the hereditary factor may play a role. In addition, there is evidence that it is an estrogen-dependent tumor. Surgical treatment varies according to its location, symptoms, size, and the desire to preserve fertility or menstruation. Calcification of uterine fibroids, as in our patient's case, has a frequency of 4-10%. They usually occur as a consequence of circulatory disturbances in fibroids and in elderly patients.
APA, Harvard, Vancouver, ISO, and other styles
2

Machado, Priscilla, Kathleen Gillmore, Allison Tan, Carin Gonsalves, and Flemming Forsberg. "Quantitative Assessments of Uterine Fibroids pre and post Uterine Artery Embolization." In 2020 IEEE International Ultrasonics Symposium (IUS). IEEE, 2020. http://dx.doi.org/10.1109/ius46767.2020.9251642.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Chandrasekaran, Parthasarathy K, Gowtham R, and U. Mutheeswaran. "Prediction of Uterine Fibroids from Ultrasound Images." In 2023 3rd International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE). IEEE, 2023. http://dx.doi.org/10.1109/icacite57410.2023.10183040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Faisant, Marie-Caroline, Benzion Amoyav, Quentin Perrier, Laura Eling, and Jayashree Rangaraja. "Intrauterine HIFU: A New Treatment for Uterine Fibroids." In Special Session on Designing Future Health Innovations as Needed. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0007695205950602.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McCaffrey, Katherine, Karen Rose, and John P. Abraham. "Numerical Simulation of Cryosurgery as a Potential Treatment for Uterine Fibroids." In 2010 14th International Heat Transfer Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/ihtc14-22106.

Full text
Abstract:
Nearly 80% of all women may suffer from menorrhagia caused by uterine fibroids (leiomyomas) which are benign tumors made up of muscle and fibrous tissue that grow from the muscular wall of the uterus. The vast majority of women whose symptoms are strong enough to require treatment obtain a hysterectomy. Other treatment options which are less invasive than hysterectomy include thermal therapies such as thermal ablation or cryosurgical removal of tissue. This project numerically evaluates the efficacy of a liquid-nitrogen-based cryotherapy for the treatment of uterine fibroids. A bioheat transfer model was utilized which includes both the effects of blood perfusion and the impacts of liquid-to-solid phase change. Changes in all physical properties including thermal conductivity, heat capacity, and perfusion rate were taken into account as the tissue passed through a range of temperatures where it would be transitioning from unfrozen to fully frozen. The numerical model was based on a one-dimensional unsteady bioheat equation. The results show that even for the direct-contact cooling, it is unlikely that intracellular ice would form during the procedure. On the other hand, based on data obtained from previous cell-survival studies, it was found that necrosis would occur when the cooling rates exceeded 30°/min. According to the present numerical results, necrosis would occur within the tissue up to a depth of approximately 5.8 mm, thereby ensuring that sufficient tissue would be cryosurgically destroyed to result in effective treatment.
APA, Harvard, Vancouver, ISO, and other styles
6

McCaffrey, Katherine L., Karen M. Rose, and John P. Abraham. "Cryosurgery as an Alternative Treatment for Menorrhagia and Uterine Fibroids." In ASME 2010 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2010. http://dx.doi.org/10.1115/sbc2010-19060.

Full text
Abstract:
Nearly 80% of all women may suffer from uterine fibroids (leiomyomas) and/or menorrhagia, which is a condition where the uterus walls bleed abnormally. The vast majority of women whose symptoms are strong enough to require treatment obtain a hysterectomy. Other treatment options which are less invasive than hysterectomy include thermal therapies such as thermal ablation or cryosurgical removal of tissue. This project numerically evaluates the efficacy of a liquid-nitrogen-based cryotherapy for the treatment of uterine fibroids. A bioheat transfer model was utilized which included both the effects of blood perfusion and the impacts of liquid-to-solid phase change. An upper limit on the cooling rate was obtained by simulating a direct contact between the probe tip and the inner lining of the uterus. Calculations were carried out for a one-minute treatment duration with 720 calculation nodes which spanned the thickness of the uterine wall. Results obtained from the calculations allowed a determination of the cooling rate at each nodal location within the tissue. Based on data obtained from previous cell-survival studies, it was found that necrosis would occur within the tissue up to a depth of approximately 5.8 mm.
APA, Harvard, Vancouver, ISO, and other styles
7

Funaki, Kaoru. "The Early Effects of MRgFUS in Treating Uterine Fibroids." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Okesola, Mary A., Olubanke O. Ogunlana, Bose E. Adegboye, Israel S. Afolabi, Folasade A. Bello, and Adewale J. Lasisi. "The Multi-risk Factors Promoting Uterine Fibroids in Women." In 2023 International Conference on Science, Engineering and Business for Sustainable Development Goals (SEB-SDG). IEEE, 2023. http://dx.doi.org/10.1109/seb-sdg57117.2023.10124571.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Patel, Neeral, Dermot Mallon, Alison Amoah, Ailing Fagan, and Mohamad Hamady. "Uterine Artery Embolisation for Giant Fibroids: Does Size Matter?" In PAIRS Annual Meeting. Thieme Medical and Scientific Publishers Pvt. Ltd., 2019. http://dx.doi.org/10.1055/s-0041-1730611.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Patel, Neeral, Riham Dessouky, Alison Amoah, Aisling Fagan, and Mohamad Hamady. "Uterine Artery Embolisation for Submucosal Fibroids: Efficacious and Safe?" In PAIRS Annual Meeting. Thieme Medical and Scientific Publishers Pvt. Ltd., 2019. http://dx.doi.org/10.1055/s-0041-1730632.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Uterine fibroids"

1

Velentgas, Priscilla, Donna Messner, and Evan Myers. Comparing Patient-Centered Outcomes after Treatment for Uterine Fibroids. Patient-Centered Outcomes Research Institute (PCORI), May 2018. http://dx.doi.org/10.25302/5.2018.ce.12114430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Yishan, Jingsong Yi, Shunhe Lin, Xi Xie, Xishi Liu, and Sun-Wei Guo. Reproductive outcomes in women with uterine fibroids: High-intensity focused ultrasound vs. myomectomy. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2024. http://dx.doi.org/10.37766/inplasy2024.4.0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Yanhui. The curative effect of laparoscopic single port and traditional laparoscopic treatment of uterine leiomyoma: meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2023. http://dx.doi.org/10.37766/inplasy2023.3.0071.

Full text
Abstract:
Review question / Objective: Single-port laparoscopy has been proposed as an ideal surgical method for treating uterine leiomyoma, which can effectively remove the lesion, reduce hemoglobin loss, and achieve good cosmetic results. Therefore, we retrieved related studies for a meta-analysis to evaluate the effects of single-hole laparoscopic resection of uterine fibroids, haemoglobin loss, and scar cosmetic effect. Eligibility criteria: (1) the type of study should be a randomized controlled study; (2) the participants should be women receiving single-hole laparoscopic laparoscopy or conventional laparoscopy; (3) the type of intervention, which should compare single-hole laparoscopic laparoscopy with uterine leiomyoma, and excluding the study with conventional laparoscopy, and (4) regarding the type of outcome, the study should measure at least one outcome of interest mentioned below.
APA, Harvard, Vancouver, ISO, and other styles
4

Gao, Li-nan, Lian-gang Ge, Ming-zhe Zhu, and Xin-xin Yao. Association between tumor necrosis factor α and uterine fibroids: a protocol of systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Myers, Evan, Raymond Anchan, Vanessa Jacoby, John Lipman, Erica Marsh, G. Larry Maxwell, Wanda Nicholson, et al. Comparing Options for Treating Uterine Fibroids through a Patient Information Registry – The COMPARE-UF Study. Patient-Centered Outcomes Research Institute (PCORI), April 2023. http://dx.doi.org/10.25302/04.2023.mou.ahrq2013001pr.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Li, Siting, Huimin Li, Caifeng Liu, Chenglin Duanmu, and Zhiguo Wang. Network meta-analysis of 7 kinds of Chinese patent medicine combined with mifepristone in the treatment of uterine fibroids. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yin, Xiaoxiao, Liuqing He, Haofei Xu, Shunping Lou, Ying Tan, Yunqing Wang, and Xinyu Luo. Updating the efficacy and safety of different doses of mifepristone in the treatment of uterine fibroids: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2024. http://dx.doi.org/10.37766/inplasy2024.6.0075.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Liu, Lu, Tianfu Wang, and Baiying Lei. High-intensity focused ultrasound ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2020. http://dx.doi.org/10.37766/inplasy2020.8.0012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

dai, xiaoxia, bing liu, juan li, and xiang liu. Clinical effect of mifepristone combined with Guizhi Fuling capsule in the treatment of uterine fibroids：a meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Uterine fibroids' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography